8-Hydroxyquinoline → HCID 20079037, compound
Reaction equation
[OH:1][C:2]1[CH:3]=[CH:4][CH:5]=[C:6]2[C:11]=1[N:10]=[CH:9][CH:8]=[CH:7]2.[NH:12]1[CH2:17][CH2:16][NH:15][CH2:14][CH2:13]1.[CH3:18][C:19](C)([O-:21])[CH3:20].[K+].[OH-].[Na+].[CH2:26]1[CH2:30]O[CH2:28][CH2:27]1>>[C:26]1([CH:30]([C:2]2[CH:3]=[CH:4][CH:5]=[CH:6][CH:11]=2)[N:12]2[CH2:17][CH2:16][N:15]([CH2:18][CH:19]([OH:21])[CH2:20][O:1][C:2]3[CH:3]=[CH:4][CH:5]=[C:6]4[C:11]=3[N:10]=[CH:9][CH:8]=[CH:7]4)[CH2:14][CH2:13]2)[CH:9]=[CH:8][CH:7]=[CH:28][CH:27]=1Participants
Procedure
In 5 ml of dried THF were dissolved 200 mg of 8-hydroxyquinoline and 319 mg of the piperazine compound prepared in Example 23-(b), and 120 mg of potassium t-butoxide was further added thereto. The liquid was then stirred at room temperature for 5 days, and 20 ml of a 1N aqueous sodium hydroxide solution was poured into the liquid, followed by extracting with 100 ml of methylene chloride. Afterward, the methylene chloride solution was washed with a dilute aqueous sodium hydroxide solution, and was then dried with an anhydrous Glauber's salt. After the solvent was distilled off, the residue was purified through a silica gel column chromatograph. On allowing an effluent solvent of chloroform:methanol=50:1 to flow therethrough, the desired product 8-[3-(4-diphenylmethylpiperazine-1-yl)-2-hydroxypropoxy]-quinoline was obtained in a powdery state in an amount of 45 mg.
Workup
- additionwas further added
- extractionby extracting with 100 ml of methylene chloride
- washAfterward, the methylene chloride solution was washed with a dilute aqueous sodium hydroxide solution
- dry with materialwas then dried with an anhydrous Glauber's salt
- distillationAfter the solvent was distilled off
- customthe residue was purified through a silica gel column chromatograph
Sources & evidence
- ORD record
- ord-97066ca49a0c436b8b4662ebf1996518
- Source dataset
- uspto-grants-1995_04
- Patent number
- US05405843
Reaction notes
Loading…